DaVita Appoints New Chief Accounting Officer

TL;DR

DaVita names Joel Ackerman as CAO, starting Sept 13th. He gets $350k base + bonus + stock.

AI Summary

DaVita Inc. announced on September 9, 2024, the appointment of Joel L. Ackerman as Chief Accounting Officer, effective September 13, 2024. He will receive an annual base salary of $350,000 and a target annual bonus of 50% of his base salary. Ackerman will also be granted 10,000 restricted stock units (RSUs) vesting over three years.

Why It Matters

The appointment of a new Chief Accounting Officer is a key leadership change that can impact financial reporting accuracy and investor confidence.

Risk Assessment

Risk Level: low — This filing primarily concerns an executive appointment and compensation, which is standard corporate activity.

Key Numbers

• $350,000 — Annual Base Salary (For new Chief Accounting Officer Joel L. Ackerman)
• 50% — Target Annual Bonus (Percentage of base salary for Joel L. Ackerman)
• 10,000 — Restricted Stock Units (Granted to Joel L. Ackerman, vesting over three years)

Key Players & Entities

• DaVita Inc. (company) — Registrant
• Joel L. Ackerman (person) — Appointed Chief Accounting Officer
• $350,000 (dollar_amount) — Annual base salary for Joel L. Ackerman
• September 13, 2024 (date) — Effective date of Joel L. Ackerman's appointment
• 10,000 (dollar_amount) — Number of restricted stock units granted to Joel L. Ackerman

FAQ

From the Filing

0001206774-24-000897.txt : 20240913 0001206774-24-000897.hdr.sgml : 20240913 20240913161538 ACCESSION NUMBER: 0001206774-24-000897 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240909 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240913 DATE AS OF CHANGE: 20240913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 241297927 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva4379221-8k.htm CURRENT REPORT false 0000927066 0000927066 2024-09-09 2024-09-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549         Form 8-K         CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 9, 2024           DAVITA INC.   (Exact name of registrant as specified in its charter)               DE 1-14106 51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)                   2000 16th Street Denver , CO 80202 (Address of principal executive offices including Zip Code) ( 720 ) 631-2100 (Registrant’s telephone number, including area code) Not applicable (Former name or former address, if changed since last report)         Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:       Title of each class: Trading symbol(s): Name of each exchange on which registered: Common Stock, $0.001 par value DVA New York Stock Exchange       Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐     Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Operating Officer Transition On